Find any stock by ticker or company name
Barcha huquqlar himoyalangan.
39.03
0.00 (0.00%)
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentation of the chin region. Engineered for deep injection to build and shape on bone, Restylane Shaype delivers a unique bone-mimicking effect, enabling immediate, natural-looking structural enhancement in the lower face without surgery.1-3 The lower face plays a pivotal role in overall facial balance, influencing propor.
There is no data to display
